» Articles » PMID: 34578235

Role of and Other Environmental Factors in the Development of Gastric Dysbiosis

Abstract

Microbiomes are defined as complex microbial communities, which are mainly composed of bacteria, fungi, and viruses residing in diverse regions of the human body. The human stomach consists of a unique and heterogeneous habitat of microbial communities owing to its anatomical and functional characteristics, that allow the optimal growth of characteristic bacteria in this environment. Gastric dysbiosis, which is defined as compositional and functional alterations of the gastric microbiota, can be induced by multiple environmental factors, such as age, diet, multiple antibiotic therapies, proton pump inhibitor abuse, status, among others. Although colonization has been reported across the world, chronic infection may lead to serious consequences; therefore, the infection must be treated. Multiple antibiotic therapy improvements are not always successful because of the lack of adherence to the prescribed antibiotic treatment. However, the abuse of eradication treatments can generate gastric dysbiotic states. Dysbiosis of the gastric microenvironment induces microbial resilience, due to the loss of relevant commensal bacteria and simultaneous colonization by other pathobiont bacteria, which can generate metabolic and physiological changes or even initiate and develop other gastric disorders by non- bacteria. This systematic review opens a discussion on the effects of multiple environmental factors on gastric microbial communities.

Citing Articles

Fusobacterium nucleatum confirmed in gastric biopsies of patients without Helicobacter pylori.

Kamali N, Talebi Bezmin Abadi A, Rahimi F, Forootan M BMC Res Notes. 2025; 18(1):109.

PMID: 40069707 PMC: 11899000. DOI: 10.1186/s13104-025-07165-8.


Microbiome Dynamics: A Paradigm Shift in Combatting Infectious Diseases.

Kamel M, Aleya S, Alsubih M, Aleya L J Pers Med. 2024; 14(2).

PMID: 38392650 PMC: 10890469. DOI: 10.3390/jpm14020217.


Dysbiosis by Eradication of Infection Associated with Follicular Gastropathy and Pangastropathy.

Gomez-Ramirez U, Nolasco-Romero C, Contreras-Rodriguez A, Zuniga G, Mendoza-Elizalde S, Prado-Galbarro F Microorganisms. 2023; 11(11).

PMID: 38004759 PMC: 10673246. DOI: 10.3390/microorganisms11112748.


Gastric microbiome changes in relation with Helicobacter pylori resistance.

Dewayani A, Fauzia K, Alfaray R, Waskito L, Doohan D, Rejeki P PLoS One. 2023; 18(5):e0284958.

PMID: 37200323 PMC: 10194900. DOI: 10.1371/journal.pone.0284958.


GG supplementation on eradication rate and dyspepsia in infection treated with three-in-one bismuth quadruple therapy.

Marinelli P, Scalese G, Covelli A, Ruffa A, Bedetti G, Bruno G Front Microbiol. 2022; 13:932331.

PMID: 36545196 PMC: 9760799. DOI: 10.3389/fmicb.2022.932331.

References
1.
de Vries A, Kuipers E, Rauws E . Helicobacter pylori eradication and gastric cancer: when is the horse out of the barn?. Am J Gastroenterol. 2009; 104(6):1342-5. DOI: 10.1038/ajg.2008.15. View

2.
Cao L, Yu J . Effect of Helicobacter pylori Infection on the Composition of Gastric Microbiota in the Development of Gastric Cancer. Gastrointest Tumors. 2015; 2(1):14-25. PMC: 4668788. DOI: 10.1159/000380893. View

3.
Rajilic-Stojanovic M, de Vos W . The first 1000 cultured species of the human gastrointestinal microbiota. FEMS Microbiol Rev. 2014; 38(5):996-1047. PMC: 4262072. DOI: 10.1111/1574-6976.12075. View

4.
Watari J, Chen N, Amenta P, Fukui H, Oshima T, Tomita T . Helicobacter pylori associated chronic gastritis, clinical syndromes, precancerous lesions, and pathogenesis of gastric cancer development. World J Gastroenterol. 2014; 20(18):5461-73. PMC: 4017061. DOI: 10.3748/wjg.v20.i18.5461. View

5.
Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M . Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001; 345(11):784-9. DOI: 10.1056/NEJMoa001999. View